WallStreetZenWallStreetZen

NASDAQ: FOLD
Amicus Therapeutics Inc Stock Ownership - Who owns Amicus Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Amicus Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Samantha ProutChief Accounting Officer2024-04-157,027$10.66
$74.91kSell
Bradley L. CampbellPresident and CEO2024-04-017,500$8.61
$64.57kBuy
Bradley L. CampbellPresident and CEO2024-04-017,500$11.67
$87.50kSell
Bradley L. CampbellPresident and CEO2024-03-1513,375$11.48
$153.55kSell
Glenn SblendorioDirector2024-03-0715,000$2.80
$42.00kBuy
Michael RaabDirector2024-03-0515,000$2.80
$42.00kBuy
Margaret G. McGlynnDirector2024-03-057,500$2.80
$21.00kBuy
Margaret G. McGlynnDirector2024-03-057,500$13.40
$100.50kSell
Margaret G. McGlynnDirector2024-03-047,500$2.80
$21.00kBuy
Margaret G. McGlynnDirector2024-03-047,500$13.29
$99.68kSell

1 of 13

FOLD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when FOLD insiders and whales buy or sell their stock.

FOLD Shareholders

What type of owners hold Amicus Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Perceptive Advisors LLC12.53%37,018,271$380.55MInsider
Vanguard Group Inc9.65%28,492,486$292.90MInstitution
Perceptive Advisors LLC9.50%28,057,456$288.43MInstitution
Avoro Capital Advisors LLC9.28%27,400,000$281.67MInstitution
Blackrock Inc7.78%22,988,139$236.32MInstitution
Jpmorgan Chase Co6.04%17,848,531$183.48MInstitution
Wellington Management Group LLP5.14%15,190,024$156.15MInstitution
Redmile Group LLC5.02%14,828,321$152.44MInstitution
Morgan Stanley4.51%13,327,897$137.01MInstitution
State Street Corp4.46%13,163,085$135.32MInstitution

1 of 3

FOLD vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
FOLD66.56%33.44%Net SellingNet Selling
XENE95.45%3.29%Net SellingNet Selling
IDYA88.70%10.03%Net SellingNet Selling
CRNX85.00%15.00%Net SellingNet Selling
IMCR75.26%0.07%Net BuyingNet Buying
View Top Biotech Stocks

Amicus Therapeutics Stock Ownership FAQ

Who owns Amicus Therapeutics?

Amicus Therapeutics (NASDAQ: FOLD) is owned by 107.87% institutional shareholders, 54.19% Amicus Therapeutics insiders, and 0.00% retail investors. Perceptive Advisors LLC is the largest individual Amicus Therapeutics shareholder, owning 37.02M shares representing 12.53% of the company. Perceptive Advisors LLC's Amicus Therapeutics shares are currently valued at $380.55M.

If you're new to stock investing, here's how to buy Amicus Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.